2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on HER2+ Esophageal Adenocarcinoma: Does the Addition of Trastuzumab to Trimodality Treatment Improve DFS?

0 views
December 4, 2020
Comments 0
Login to view comments. Click here to Login